מדד נזילות מהירה: MacroGenics Inc. (MGNX)

This daily price chart for MacroGenics, Inc. (MGNX) reflects the asset's dynamics, with a value of 2.89. MacroGenics, Inc. (MGNX) possesses pricing power driven by its DART platform for bispecific antibody development. Business growth relies on ADC drug test results, royalty payments from Margenza, and partnerships with industry behemoths. Additionally, the firm is competing scientifically against the largest pharma pipelines by developing high-precision oncology therapies.

This ratio assesses the ability of MacroGenics, Inc. (MGNX) to settle short-term liabilities using its most liquid assets, excluding slow-moving inventories. An analysis of the quick ratio is critical for MacroGenics, Inc. (MGNX), as cash availability determines the pace of bringing targeted antibodies to market and the success of clinical trials, regardless of external macroeconomic factors.